#Tumor necrosis factor-alpha (TNF-alpha)

[mitalipingale]

https://bundas24.com/read-blog/118482_tumor-necrosis-factor-tnf-alpha-inhibitors-market-size-overview-share-and-foreca.html

The Tumor Necrosis Factor (TNF) Alpha Inhibitors Market in 2023 is US$ 41.88 billion, and is expected to reach US$ 44.35 billion by 2031 at a CAGR of 0.7%.

[helen0086]

Progress in the Study of the Protective Effect and Mechanism of C-phycocyanin on Liver Injury

Abstract: C-phycocyanin (C-phycocyanin) is a pigment-containing protein from marine algae that has shown promising results in the treatment of many inflammatory diseases and tumors. C-alpha-cyanobilin is a pigment-containing protein from marine algae that has been shown to be effective in the treatment of various inflammatory diseases and tumors. C-alpha-cyanobilin has a protective effect on various liver diseases, such as drug-induced or toxic substance-induced liver damage, non-alcoholic fatty liver disease, hepatic fibrosis, and hepatic ischemia-reperfusion injury. The protective effect of C-alginin on liver injury is mainly realized through the regulation of signaling pathways such as nuclear factor (NF)-κB, phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) and AMP-dependent protein kinase (AMPK), and the inhibition of oxidative stress, etc., and is not toxic to normal cells. Therefore, C-alginin has a broad application prospect as a potential natural hepatoprotective marine active substance. In recent years, the research progress of the protective effect of C-alginin on liver injury and its mechanism is summarized.

 C-phycocyanin (C-phycocyanin) is a complex protein of cyanobacteria and a natural food protein pigment with pharmacological effects such as antioxidant, anti-inflammatory and anti-tumor effects, as well as fast-acting and low-toxicity, it can be used as a functional food [1-2]. C-Alginin can also enhance immunity and is safe, without causing acute and subacute toxic reactions [3]. Selenium-enriched PC has been shown to have stronger pharmacological effects [4]. Therefore, C-alginate has important research value both as a drug and a functional food, and has become a hot spot in the field of pharmaceutical research [5]. In this paper, we summarize the progress of research on the application and mechanism of C-alginin in liver diseases.

1 Ameliorative effect of C-phycocyanin on liver injury caused by drugs and toxic substances

The liver is the metabolic center of drugs and exogenous toxic substances, and metabolites are prone to liver injury. C-PC can inhibit the synthesis and release of inflammatory factors such as tumor necrosis factor (TNF)-α and interferon-γ, and increase the activities of catalase and superoxide dismutase (SOD), which can inhibit hepatic inflammation and alleviate hepatic injury [3]. It has been found that C-PC can significantly prevent thioacetamide-induced liver injury, significantly reduce the levels of alanine aminotransferase (ALT) and aliquot aminotransferase (AST), shorten the prothrombin time and reduce the hepatic histopathological damage, and improve the survival rate of rats with fulminant hepatic failure [6]. C-alginin also has a good effect on thioacetamide-induced hepatic encephalopathy, which can be seen in the reduction of tryptophan and lipid peroxidation indexes in different regions of the brain, and the enhancement of catalase and glutathione peroxidase activities in rats with fulminant hepatic failure [6].

Another study found that C-alginin not only attenuates the oxidative stress induced by 2-acetylaminofluorene and reduces the generation of reactive oxygen species (ROS) radicals, but also inhibits the phosphorylation of protein kinase B (Akt) and the nuclear translocation of nuclear factor (NF)-κB induced by 2-acetylaminofluorene, thus inhibiting the expression of multidrug resistance genes [7]. Osman et al. [8] also showed that C-alginin could normalize the levels of ALT, AST, catalase, urea, creatinine, SOD and glutathione-s-transferase in the livers of rats poisoned with carbon tetrachloride (CCl4). This result was also verified in human liver cell line (L02) [9]. C-phycocyanin can effectively scavenge ROS and inhibit CCl4-induced lipid peroxidation in rat liver [10], and C-PC can improve the antioxidant defense system and restore the structure of hepatocytes and hepatic enzymes in the liver of gibberellic acid-poisoned albino rats [11]. As a PC chromophore, phycocyanin can also significantly inhibit ROS generation and improve liver injury induced by a variety of drugs and toxic substances [10]. Liu et al. [12] found that phycocyanin showed strong anti-inflammatory effects in a CCl4-induced hepatic injury model in mice, which could significantly reduce the levels of ALT, AST, the expression of TNF-α and cytochrome C, increase the levels of albumin and SOD, and proliferate cytosolic nuclei. It can significantly reduce ALT and AST levels and the expression of TNF-α and cytochrome C, increase albumin levels and the expression of SOD and proliferating cell nuclear antigen, promote hepatocyte regeneration and improve the survival rate of mice with acute liver failure.

Gammoudi et al [13] used response surface method to optimize the extraction process of C-phycocyanin, and obtained high extraction recovery. C-phycocyanin extracted by the optimized method has the ability of scavenging hydroxyl, superoxide anion and nitric oxide radicals as well as the ability of metal chelating, and it has stronger antioxidant effect; C-PC significantly increased the activity of SOD and inhibited the increase of ALT, AST, and bilirubin in cadmium-poisoned rats. C-PC significantly increased the activity of SOD and inhibited the increase of ALT, AST and bilirubin in rats with cadmium poisoning. The above studies show that C-phycocyanin can effectively protect liver injury caused by drugs and toxic substances, and has the efficacy as the basis for drug development.

2 Preventive effect of C-alginin on hepatic fibrosis

Liver fibrosis is an inevitable process in the development of various chronic liver diseases and may be reversed with early and timely treatment. The key to liver fibrosis is the activation of hepatic stellate cells. Previous studies have found that low-dose C-alginin combined with soy isoflavones can inhibit hepatic stellate cell activation by inhibiting the activity of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase［14］, but it is not clear whether C-alginin alone can inhibit the activity of NADPH oxidase. Therefore, the combination of C-algin and soy isoflavones at appropriate doses may have a preventive effect on liver fibrosis in high-risk groups. C-alginin may inhibit the progression of NADPH by suppressing oxidative damage, thereby inhibiting the development of hepatic fibrosis [15].

Epithelial mesenchymal transition (EMT) is one of the key mechanisms contributing to the development of fibrotic diseases. C-alginin inhibits transforming growth factor β1 (TGF-β1)-induced human EMT [16]. Although the effect of C-alginin on EMT in hepatic fibrosis has not been reported, it has been found that C-alginin can reduce pulmonary fibrosis by inhibiting epithelial mesenchymal transition [17]. Another study found that C-alginin could reduce the expression of α-smooth muscle actin (α-SMA) and connective tissue growth factor (CTGF) mRNA in human dermal fibroblasts and alleviate fibrous contracture [18]. The results of these studies also have significance for the inhibition of hepatic fibrosis, and provide a theoretical basis for the further study of C-PC as a potential antifibrotic drug.

3 Protective effect of C-alginin on hepatic ischemia-reperfusion injury

Liver ischemia/reperfusion injury is an important clinicopathophysiological phenomenon. It was found that the addition of two different doses (0.1 g/L and 0.2 g/L) of C-alginin to the Krebs Henseleit preservation solution significantly decreased hepatic ALT, AST and alkaline phosphatase activities, and reduced the rate of lipid peroxidation and malondialdehyde content in an isolated perfused rat liver model, and increased the activities of hepatic glutathione-s-transferase and glutathione peroxidase, as well as sulfhydryl groups in hepatic tissue. On the other hand, it can increase the activities of hepatic glutathione-s-transferase and glutathione peroxidase and the content of sulfhydryl groups in liver tissues, therefore, C-alginin can significantly reduce hepatic ischemia/reperfusion injury as an antioxidant [19]. In isolated perfused mouse livers, it was found that C-alginin significantly reduced the phagocytosis and respiratory burst activity of hepatic macrophages (Kupffer cells), attenuated cytotoxicity and inflammation induced by highly active Kupffer cells, and dose-dependently inhibited carbon phagocytosis and carbon-induced oxygen uptake by perfused livers, and then inhibited the increase of hepatic nitric oxide synthase activity induced by gonadotropins [20]. and thus inhibit the thyroid hormone-induced elevation of hepatic nitric oxide synthase activity [20].

However, C-alginin has a very short half-life in vivo, which limits its application in vivo. It was found that the use of polyethylene glycol-b-(polyglutamic acid-g-polyethyleneimine), a macromolecular material with good drug-carrying capacity and slow-release properties, as a nanocarrier of C-alginin could solve this problem, and the release of C-alginin could be delayed by subcutaneous injection into the abdominal region of rats, which could attenuate islet damage caused by hepatic ischemia/reperfusion and enhance the function of the islets [21]. This study broadens the scope of application of C-alginin in vivo and improves the therapeutic effect of C-alginin.

4 Inhibitory effect of C-alginin on hepatocellular carcinoma

It was found that C-alginin significantly reduced the expression of matrix metalloproteinase (MMP)-2 and MMP-9 and the expression of tissue inhibitor of metalloproteinase 2 (TIMP2) mRNA in human hepatocellular carcinoma cells (HepG2 cells) [22]. C-alginin is a natural photosensitizer, and photodynamic therapy (PDT) mediated by alginin microcystin induced a large accumulation of ROS in HepG2 cells, which promoted mitochondrial damage and cytochrome C release, and led to apoptosis of hepatocellular carcinoma cells [23].

Liu et al. [24] used nanoscale C-alginate particles prepared by lactobionic acid grafting and adriamycin loading to enhance the growth inhibition of HepG2 cells when combined with chemo-PDT, and the C-alginate particles could effectively accumulate and diffuse in tumor multicellular spheres. In vitro and in vivo studies on the effects of selenium-enriched PCs on PDT in hepatocellular carcinoma showed that selenium-enriched PCs could migrate from lysosomes to mitochondria in a time-dependent manner, and that selenium-enriched PCs could induce the death of tumor cells through the generation of free radicals in vivo, increase the activities of antioxidant enzymes in vivo, induce mitochondria-mediated apoptosis, and inhibit autophagy, thus offering a relatively safe pathway to tumor treatment and showing new development perspectives [4]. It can provide a relatively safe way to treat tumors and shows a new development prospect [4].

Lin et al. [25] combined C-phycocyanin with single-walled carbon nanohorns and prepared phycocyanin-functionalized single-walled carbon nanohorn hybrids, which enhanced the photostability of C-phycocyanin and protected the single-walled carbon nanohorns from adsorption of plasma proteins, and synergistically used with PDT and photothermal therapy (PTT) to treat tumors. C-phycocyanin covalently coupled with biosilica and PDT or non-covalently coupled with indocyanine green and PTT on tumor-associated macrophages can also increase the apoptosis rate of tumor cells [26-27]. The development of PDT and PTT synergistic methods for the treatment of cancer has broadened the application of C-PC and enhanced its value in the treatment of hepatocellular carcinoma.

In addition, C-phycocyanin can inhibit the expression of multidrug-resistant genes in HepG2 cells through NF-κB and activated protein-1 (AP-1)-mediated pathways, and C-phycocyanin increases the accumulation of adriamycin in HepG2 cells in a dose-dependent manner, which results in a 5-fold increase in the susceptibility of cells to adriamycin [28]. Even in adriamycin-resistant HepG2 cells, C-PC induced the activation of apoptotic pathways such as cytochrome C and caspase-3 [29], and the results of Prabakaran et al. [30] also confirmed the inhibitory effect of C-PC on the proliferation of HepG2 cells, mediated by the inactivation of BCR-ABL signaling and the downstream PI3K/Akt pathway. mediated by BCR-ABL signaling and inactivation of downstream PI3K/Akt pathway. In addition, C-phycocyanin modifies the mitochondrial membrane potential and promotes apoptosis in cancer cells [30]. Currently, C-phycocyanin is a synergistic molecule with other drugs that have been widely used in the treatment of cancer [31]. The above studies demonstrate that C-phycocyanin has good therapeutic potential in the field of hepatocellular carcinoma.

5 Amelioration of metabolic syndrome and non-alcoholic fatty liver disease by C-phycocyanin

It has been found that C-alginin can reduce ALT and AST levels, decrease ROS production and NF-κB activation, and attenuate hepatic fibrosis in rats induced by high-fat choline-deficient diets, and thus C-alginin has a protective effect on NAFLD rats through anti-inflammatory and antioxidant mechanisms [15].

Another study on the effects of aqueous extract of Spirulina (mainly C-alginin) on NAFLD induced by a high-calorie/high-fat Western diet in C57Bl/6J mice showed that aqueous extract of Spirulina significantly improved glucose tolerance, lowered plasma cholesterol, and increased ursodeoxycholic acid in bile in mice [32]. Kaspi-Chadli et al. Kasbi-Chadli et al. [33] showed that aqueous extract of Spirulina could reduce cholesterol and sphingolipid levels in the liver and aortic cholesterol levels in hamsters fed a high-fat diet by significantly decreasing the expression of hydroxy-3-methylglutaryl-coenzyme A reductase (HMG CoA) gene, a limiting enzyme for cholesterol synthesis, and TGF-β1 gene, and that ursodeoxycholic acid levels in the feces of hamsters fed high-fat diets were increased in the high Spirulina aqueous extract treatment group.

A daily dose of C-alginin-enriched Spirulina can reduce the harmful effects of oxidative stress induced by a diet rich in lipid peroxides [34]. Ma et al. [35] found that C-alginin promoted the phosphorylation of hepatocyte AMP-dependent protein kinase (AMPK) in vivo and ex vivo, and increased the phosphorylation of acetyl coenzyme A carboxylase. In the treatment of NAFLD in mice, C-alginin can improve liver inflammation by up-regulating the expression of phosphorylated AMPK and AMPK-regulated transcription factor peroxisome proliferator-activated receptor α (PPAR-α) and its target gene, CPT1, and by down-regulating the expression of pro-inflammatory factors such as TNF-α and CD36 [35]. This suggests that C-phycocyanin can also improve lipid deposition in the liver through the AMPK pathway.

Endothelial dysfunction is associated with hypertension, atherosclerosis and metabolic syndrome. Studies in animal models of spontaneous hypertension have shown that long-term administration of C-alginin may improve systemic blood pressure in rats by increasing aortic endothelial nitric oxide synthase levels, with a dose-dependent decrease in blood pressure, and thus C-alginin may be useful in preventing endothelial dysfunction-related diseases in the metabolic syndrome [36]. In the offspring of ApoE-deficient mice fed C-alginate during gestation and lactation, male littermates had an elevated hepatic reduced/oxidized glutathione ratio and significantly lower hepatic SOD and glutathione peroxidase gene expression.

C-PC is effective in preventing atherosclerosis in adult hereditary hypercholesterolemic mice [37]. In vitro, C-phycocyanin also improved glucose production and expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase) in high-glucose-induced insulin-resistant HepG2 cells [38]. C-alginin also increases glucose uptake in high glucose-induced insulin-resistant HepG2 cells through the insulin receptor substrate (IRS)/PI3K/Akt and Sirtuin-1 (SIRT1)/liver kinase B1 (LKB1)/AMPK signaling pathways, activates glycogen synthase, and increases the amount of glycogen [38]. C-phycocyanin can improve blood glucose and fasting serum insulin levels in tetracycline-induced diabetic mice [39]. Therefore, C-phycocyanin can maintain cellular glucose homeostasis by improving insulin resistance in hepatocytes.

6 Hepatoprotective role of C-phycocyanin in other liver diseases

Studies have shown that C-alginin can inhibit total serum cholesterol, triacylglycerol, LDL, ALT, AST, and malondialdehyde levels in mice modeled with alcoholic liver injury, significantly increase SOD levels in the liver, and promote the activation and proliferation of CD4+ T cells, which can have an ameliorative effect on alcoholic liver injury [40]. In addition, C-phycocyanin may enhance the intestinal barrier function, regulate the intestinal flora, reduce the translocation of bacteria and metabolites to the liver, and inhibit the activity of the Toll-like receptor 4 (TLR4)/NF-κB pathway, which may reduce the inflammation of the liver and prevent the occurrence of hepatic fibrosis in mice [41]. In mice with X-ray radiation-induced liver injury, C-phycocyanin can reduce radiation-induced DNA damage and oxidative stress injury by up-regulating the expression of nuclear factor (NF)-E2-related factor 2 (Nrf2) and downstream genes, such as HO-1, and play a hepatoprotective role by enhancing the activities of SOD and glutathione peroxidase [42].

7 Outlook

Liver fibrosis is the common final process of chronic liver diseases, and there is no effective therapeutic drug at present. Although some research progress has been made in the field of traditional Chinese medicine (TCM) on the reversal of liver fibrosis [43], its toxicological effects have not yet been clarified. Although the incidence of viral hepatitis has gradually decreased with the development and popularization of vaccines and antiviral drugs, the incidence of drug-induced liver injury (DILI) and liver diseases such as NAFLD has been increasing year by year with the improvement of people's living conditions [44]. Therefore, there is an urgent need to find drugs or nutrients that can help maintain normal hepatocyte function and effectively inhibit liver inflammation and fibrosis. C-alginin, with its anti-inflammatory, antioxidant, and antitumor effects, as well as good food coloring, has a wide range of applications in both the pharmaceutical and food industries.

References:

［ 1 ］ LIU Q, HUANG Y, ZHANG R, et al. Medical aapplication of spirulina platensis derived C-phycocyanin ［J］.   Evid Based Complement Alternat Med, 2016, 2016: 7803846. doi: 10. 1155/ 2016/7803846.

[2] BRAUNE S , KRÜGER-GENGE A , KAMMERER S , et al. Phycocyanin from Arthrospira platensis as potential anti-cancer drug: review of in vitro and in vivo studies[J]. studies［J］. Life (Basel), 2021, 11 (2): 91. doi:10.3390/life11020091.

［3］ GROVER P, BHATNAGAR A, KUMARI N, et al. C-phycocyanin- a novel protein from spirulina platensis- in vivo toxicity, antioxidant and immunomodulatory studies[J].  Saudi J Biol Sci, 2021, 28(3):1853-1859. doi: 10. 1016/j.sjbs.2020.12.037.

[4] LIU Z, FU X, HUANG W, et al. Photodynamic effect and mechanism study of selenium-enriched phycocyanin from spirulina platensis against liver tumours. ［J Photochem Photobiol B] J Photochem Photobiol B, 2018, 180: 89-97. doi: 10. 1016/j.jphotobiol.2017.12.020.

［5］ JIANG L, WANG Y, YIN Q, et al. Phycocyanin: a potential drug for cancer treatment［J］.  J Cancer, 2017, 8 (17): 3416-3429. doi: 10.7150/jca.21058.

［6］ SATHYASAIKUMAR K V, SWAPNA I, REDDY P V, et al. Co- administration of C-phycocyanin ameliorates thioacetamide- induced hepatic encephalopathy in Wistar rats[J]. J Neurol Sci, 2007, 252(1):67-75. doi: 10. 1016/j.jns.2006.10.014.

[7] ROY K R , NISHANTH R P , SREKANTH D , et al. C- phycocyanin ameliorates 2-acetylaminofluorene induced oxidative stress and MDR1 expression in the liver of albino mice [J]. of albino mice[J]. Hepatol Res, 2008, 38(5): 511-520. doi: 10.1111/j. 1872-034X. 2007. 00290.x.

［8］ OSMAN A, SALAMA A, EMAM MAHMOUD K, et al. Alleviation of carbon tetrachloride-induced hepatocellular damage and oxidative stress in rats by anabaena oryzae phycocyanin[J]. J Food Biochem, 2021, 45(1):e13562. doi:10.1111/jfbc.13562.

［9］ OU Y, ZHENG S, LIN L, et al. Protective effect of C-phycocyanin against carbon tetrachloride-induced hepatocyte damage in vitro and in vivo［J］. Chem Biol Interact, 2010, 185(2): 94-100. doi: 10. 1016/j.cbi.2010.03.013.

[10] BHAT V B, MADYASTHA K M. C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro [J].  Biochem Biophys Res Commun, 2000, 275(1): 20-25. doi: 10. 1006/bbrc.2000.3270.

［ 11］ HUSSEIN M M, ALI H A, AHMED M M. Ameliorative effects of phycocyanin against gibberellic acid induced hepatotoxicity［J］. Pestic Biochem Physiol, 2015, 119: 28-32. doi: 10. 1016/j. pestbp. 2015.02.010.

［ 12］LIU J, ZHANG Q Y, YU L M, et al. Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury mice[J]. World J Gastroenterol, 2015, 21(18):5465-5472. doi:10.3748/wjg.v21.i18.5465.

[13] GAMMOUDI S, ATHMOUNI K, NASRI A, et al. Optimization,  isolation, characterization and hepatoprotective effect of a novel pigment-protein complex (phycocyanin) producing microalga: phormidium versicolorNCC-466 using response surface methodology ［J］. versicolorNCC-466 using response surface methodology ［J］.  Int J Biol Macromol, 2019, 137: 647-656. doi: 10. 1016/j.    ijbiomac.2019.06.237.

[14] MCCARTY M F , BARROSO-ARANDA J , CONTRERAS F. Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells[J]. Med Hypotheses, 2009, 72(3):330-332. doi: 10. 1016/j.mehy.2008. 07.045.

［15］PAK W, TAKAYAMA F, MINE M, et al. Anti-oxidative and anti- inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis［J］. J Clin Biochem Nutr, 2012, 51(3):227-234. doi:10.3164/jcbn.12-18.

[16] PATTARAYAN D, RAJARAJAN D, SIVANANTHAM A, et al. C- phycocyanin suppresses transforming growth factor- β 1-induced epithelial mesenchymal transition in human epithelial cells [J]. Pharmacol Rep, 2017, 69(3): 426-431. doi: 10. 1016/j. pharep. 2016.12.013.

［ 17］LI C, YU Y, LI W, et al. Phycocyanin attenuates pulmonary fibrosis via the TLR2-MyD88-NF- κB signaling pathway［J］.  Sci Rep, 2017, 7 (1): 5843. doi: 10. 1038/s41598-017-06021-5.

[18] AN E, PARK H, LEE A C. Inhibition of fibrotic contraction by C- phycocyanin through modulation of connective tissue growth factor and α-smooth muscle actin expression[J]. Tissue Eng Regen Med, 2016, 13(4):388-395. doi: 10. 1007/s13770-015-0104-5.

[19] GDARA N B, BELGACEM A, KHEMIRI I, et al. Protective effects of phycocyanin on ischemia/reperfusion liver injuries [J]. Biomed Pharmacother, 2018, 102: 196-202. doi: 10. 1016/j. biopha. 2018. 03.025.

[20] REMIREZ D, FERNÁNDEZ V, TAPIA G, et al. Influence of C- phycocyanin on hepatocellular parameters related to liver oxidative stress and kupffer cell functioning[J]. Inflamm Res, 2002, 51(7): 351-356. doi: 10. 1007/pl00000314.

[21] TONG F, TANG X, LIU D. Phycocyanin/PEG-b-(PG-g-PEI) attenuated hepatic ischemia/reperfusion-induced pancreatic islet injury and enlarged islet functionality [J]. Int J Nanomedicine, 2019, 14: 339-351. doi: 10.2147/IJN.S190938.

［22］KUNTE M, DESAI K. The inhibitory effect of C-phycocyanin containing protein extract on human matrix metalloproteinases (MMP-2) and MMP-9 in hepatocellular cancer cell line (HepG2)［J］. and MMP-9) in hepatocellular cancer cell line (HepG2) [J].  Protein J, 2017, 36(3): 186-195. doi: 10. 1007/s10930-017-9707-0.

［23］WANG C Y, WANG X, WANG Y, et al. Photosensitization of phycocyanin extracted from microcystis in human hepatocellular carcinoma cells: implication of mitochondria-dependent apoptosis ［J］. J Photochem Photobiol B, 2012, 117: 70-79. doi: 10. 1016/j.  jphotobiol.2012.09.001.

［24］LIU X, DU J, XIE Z, et al. Lactobionic acid-modified phycocyanin nanoparticles loaded with doxorubicin for synergistic chemo- photodynamic therapy［J］. therapy[J]. Int J Biol Macromol, 2021, 186: 206- 217. doi: 10. 1016/j.ijbiomac.2021.07.047.

［25］LIN Z, JIANG B P, LIANG J, et al. Phycocyanin functionalized single-walled carbon nanohorns hybrid for near-infrared light- mediated cancer phototheranostics [J].  Carbon, 2019, 143: 814- 827. doi: 10. 1016/j.carbon.2018.12.011.

[26] PU Y, WEI M, WITKOWSKI A, et al. A hybrid biomaterial of biosilica and C-phycocyanin for enhanced photodynamic effect  towards tumor cells[J]. Biochem Biophys Res Commun, 2020, 533 (3): 573-579. doi: 10. 1016/j.bbrc.2020.09.049.

[27] WAN D H, MA X Y, LIN C, et al. Noncovalent indocyanine green conjugate of C-phycocyanin: preparation and tumor-associated macrophages-targeted photothermal therapeutics[J].   Bioconjug Chem, 2020, 31(5): 1438-1448. doi: 10. 1021/acs. bioconjchem. 0c00139.

［28］NISHANTH R P, RAMAKRISHNA B S, JYOTSNA R G, et al. C- phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line[J]. Eur J Pharmacol, 2010, 649(1/3):74-83. doi: 10. 1016/j.ejphar.2010.09.011.

[29] ROY K R, ARUNASREE K M, REDDY N P, et al. Alteration of mitochondrial membrane potential by spirulina platensis C- phycocyanin induces apoptosis in the doxorubicinresistant human hepatocellular-carcinoma cell line HepG2[J].  Biotechnol Appl Biochem, 2007, 47 (Pt 3): 159-167. doi: 10. 1042/BA20060206.

[30] PRABAKARAN G, SAMPATHKUMAR P, KAVISRI M, et al. Extraction and characterization of phycocyanin from spirulina platensis and evaluation of its anticancer , antidiabetic and antiinflammatory effect[J]. Int J Biol Macromol, 2020, 153: 256- 263. doi: 10. 1016/j.ijbiomac.2020.03.009.

[31] SILVA M R O B D, M DA SILVA G, SILVA A L F D, et al. Bioactive compounds of Arthrospira spp. (spirulina) with potential anticancer activities: a systematic review[J].  ACS Chem Biol, 2021, 16 (11): 2057-2067. doi: 10. 1021/acschembio.1c00568.

[32] COUÉ M, TESSE A, FALEWÉE J, et al. Spirulina liquid extract protects against fibrosis related to non-alcoholic steatohepatitis and increases ursodeoxycholic acid [J]. Nutrients, 2019, 11 (1): 194. doi:10.3390/nu11010194.

[33] KASBI-CHADLI F, COUÉ M, AGUESSE A, et al. Spirulina liquid extract prevents metabolic disturbances and improves liver sphingolipids profile in hamster fed a high-fat diet[J]. Eur J Nutr, 2021, 60(8):4483-4494. doi: 10. 1007/s00394-021-02589-x.

[34] OULD AMARA-LEFFAD L, RAMDANE H, NEKHOUL K, et al. Spirulina effect on modulation of toxins provided by food, impact on hepatic and renal functions [J] . . Arch Physiol Biochem, 2019, 125 (2): 184-194. doi: 10. 1080/13813455.2018.1444059.

[35] MA P, HUANG R, JIANG J, et al. Potential use of C-phycocyanin in non-alcoholic fatty liver disease [J].  Biochem Biophys Res Commun, 2020, 526(4):906-912. doi: 10. 1016/j.bbrc.2020.04.001.

［36］ICHIMURA M, KATO S, TSUNEYAMA K, et al. Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome［J］. Nutr Res, 2013, 33(5): 397-405. doi: 10. 1016/j.nutres.2013.03.006.

[37] COUÉ M, CROYAL M, HABIB M, et al. Perinatal administration of C-phycocyanin protects against atherosclerosis in apoE-deficient mice by modulating cholesterol and trimethylamine-N-oxide metabolisms[J]. Arterioscler Thromb Vasc Biol, 2021, 41(12): e512-e523. doi: 10. 1161/ATVBAHA.121.316848.

［38］REN Z, XIE Z, CAO D, et al. C-phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistant hepatocytes [J]. Food Funct, 2018, 9(5): 2829-2839. doi: 10. 1039/c8fo00257f.

［39］OU Y, REN Z, WANG J, et al. Phycocyanin ameliorates alloxan- induced diabetes mellitus in mice ：involved in insulin signaling pathway and GK expression [J]. Chem Biol Interact, 2016, 247: 49- 54. doi: 10. 1016/j.cbi.2016.01.018.

[40] XIA D, LIU B, XIN W, et al. Protective effects of C-phycocyanin on alcohol-induced subacute liver injury in mice [J].  Journal of Applied Phycology, 2015, 28(2):765-772. doi: 10. 1007/s10811- 015-0677-3.

[41] XIE Y, LI W, ZHU L, et al. Effects of phycocyanin in modulating  the intestinal microbiota of mice [J].  Microbiologyopen, 2019, 8 (9): e00825. doi: 10. 1002/mbo3.825.

［42］LIU Q, LI W, QIN S. Therapeutic effect of phycocyanin on acute liver oxidative damage caused by X-ray［J］. Biomed Pharmacother, 2020, 130: 110553. doi: 10. 1016/j.biopha.2020.110553.

［43］SONG Y N, CHEN J, CAI F F, et al. A metabolic mechanism analysis of fuzheng-huayu formula for improving liver cirrhosis with traditional chinese medicine syndromes [J]. Acta Pharmacol Sin, 2018, 39(6): 942-951. doi: 10. 1038/aps.2017.101.

［44］XIAO J, WANG F, WONG N K, et al. Global liver disease burdens and research trends : analysis from a chinese perspective［J］. J Hepatol, 2019, 71(1):212-221. doi: 10. 1016/j.jhep.2019.03.004.

#phycocyanin #cphycocyanin #phycocyaninspirulina

[fivehundredwords]

Alzheimer's Disease: biomarkers and neuroimaging markers cheatsheet for research articles

As Alzheimer's Disease (AD) research skews toward understanding the brain than the pathogenic proteins, studies exploring biomarkers and neuroimaging are hopeful toward developing a method for successful prevention of AD. A biomarker is a molecule, whose presence indicates abnormality or disease, and thus, is crucial in diagnostic procedures. Levels of certain molecules is notably altered in cerebrospinal fluid and in blood plasma, which helps in diagnosing the occurrence of AD. Neuroimaging involves the use of techniques such as magnetic resonance imaging and computed tomography to observe neuronal activity in the brain. This is good news, especially for AD, as the asymptomatic stage of the disease can be identified early enough.

Although the exact function and involvement in clinical practice is not profuse, altered concentrations of these biomarkers in plasma or cerebrospinal fluid encourage further research:

Amyloid and tau serve as the unsurprising biomarkers of AD pathology.

Neurofilament-light chain (NF-L) and visinin-like protein-1 (VILIP-1) are the most promising biomarkers of neuronal injury.

Post-synaptic protein neurogranin (Ng) and pre-synaptic proteins synaptosome-associated protein-25 (SNAP-25) and synaptotagmin-1 (Syt-1) are considered major biomarkers of synaptic injury.

Brain and CSF levels of tumor necrosis factor alpha (TNF-α) and increased levels of interleukin group of proteins (ILs) indicate intensified microglial response to neuroinflammation.

TREM2 receptor and YKL-40 glycoprotein are also reliable indicators of inflammation and impaired clearance of amyloid beta.

Heart-type fatty acid-binding protein (hFABP) could be a marker for pathology in blood vessels supplying the brain. Some vascular markers also show potential as markers of vascular injury in AD: von Willebrand factor (vWF) and monokine induced by γ-interferon (MIG, also known as CXCL-9).

Concentrations of TAR-DNA binding protein (TDP-43) in the brain and plasma and serum indicate, even contribute to, inflammation, mitochondrial dysfunction, and neuronal/synaptic injury in AD.

Neuroimaging techniques reveal structural, functional, and diffusion-related activities of the neurons. To identify them, markers are tracked in images obtained. Each marker is determined with the activity and biochemistry of the group of/individual neurons being studied.

Structural MRI will show location and severity of atrophy which can be identified in grey scale images by applying programs that create analogous color grading.

Functional MRI relies on blood oxygenation level dependent (BOLD) signal which reflects changes in blood oxygenation levels in response to neural activity.

Diffusion weighted imaging (DWI) focuses on diffusion of water molecules. A tensor model is applied to images obtained from DWI. The diffusion tensor imaging (DTI) metrics thus obtained help in studying connectivity through structural integrity of white matter tracts.

Tractography involves 3-D reconstruction of white matter as observed in DWI, which provides a more detailed look into a patient’s neural networks.

In positron emission tomography (PET), markers are identified and labelled so their features or functions can be traced during this procedure to obtain a resulting PET scan. The imaging procedure is named according to its marker: amyloid-PET, tau-PET, FDG-PET, inflammation-PET, receptor-PET.

FDA approved drugs Galantamine, Rivastigmine, and Donepezil alleviate symptoms such as memory loss and confusion in mild to moderate AD, although their effects seem to be negligible. They also cause nausea and vomiting as side effects and are not suitable for every patient. Recently approved drugs, Aducanumab and Lecanemab focus on removing accumulated amyloid. Their effectiveness is still doubted on the basis of studies finding that targeting amyloid has little to do with curbing the actual progression of the disease.

bibliography -

Tarawneh R. Biomarkers: our path towards a cure for Alzheimer disease. Biomarker insights. 2020 Nov;15:1177271920976367.

Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack Jr CR, Sperling R, Cummings J, Blennow K, O’Bryant S. The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. The journal of prevention of Alzheimer's disease. 2014 Dec;1(3):181.

Medications for Alzheimer's Disease Stanford Healthcare. Accessed 21-04-2023.

[kineretprice]

All About Kineret Injection

Kineret 100 mg Injection 0.67 ml is an immunosuppressive agent. It is widely used for the treatment of rheumatoid arthritis (RA), deficiency of interleukin-1 receptor antagonist (DIRA), and neonatal-onset multisystem inflammatory disease (NOMID). Kineret 100 mg/0.67 ml price in India can vary depending on certain factors. Its active ingredient, Anakinra, is an interleukin-1 receptor antagonist. This medicine is designed to work by blocking interleukin, which is a protein responsible for inflammation in the body. This unique mechanism helps alleviate symptoms of inflammatory disorders, improving the quality of life for many patients.

How does Kineret work? The active component in Kineret, Anakinra, plays a critical role in suppressing inflammation. It does this by inhibiting interleukin-1, a protein linked to inflammatory responses and immune system activation. By shielding the body from harmful cytokines, this medicine effectively reduces swelling, redness, pain, and other symptoms associated with autoimmune and inflammatory diseases.

Uses and Benefits:

Kineret 100 mg Injection 0.67 ml is a preferred treatment option for:

Rheumatoid arthritis (RA): A chronic autoimmune condition affecting joints.

Deficiency of interleukin-1 receptor antagonist (DIRA): An ultra-rare autoinflammatory disease.

NOMID: A rare genetic inflammatory disease.

COVID-19: It is used (off-label) as part of treatment for severe inflammatory responses.

To ensure the authenticity and affordability of this life-changing medication, many patients seek reliable options for the Kineret price in India.

Common Side Effects: Although this therapeutic drug is highly effective, it may cause some side effects such as:

headache

redness or swelling at the injection site

increased cholesterol levels These side effects are typically mild and resolve on their own. However, consult your doctor if they persist or worsen.

Important Precautions:

Before using Kineret, inform your doctor about any allergies, especially to its components or E. coli, as the medication is produced using this bacteria. Patients with HIV, asthma, liver or kidney problems, epilepsy, or ongoing cancer treatments must exercise caution. A thorough medical and vaccination history is essential before starting treatment.

Kineret is not recommended for use alongside tumor necrosis factor (TNF-alpha) inhibitors like etanercept or with blood thinners such as warfarin without medical advice. Women of childbearing potential should use effective contraception during treatment, as its safety in pregnancy is not fully established.

Kineret Price in India:

For patients, hospitals, or healthcare professionals looking to know about the Kineret price in India. The price varies depending on so many factors. Indian Pharma Network (IPN) is a trusted facilitator and can ensure the legal and reliable supply of Kineret 100 mg Injection 0.67 ml. With strong ties to reputable manufacturers from all over the world, TIP makes it easier for patients to access this medicine at a very competitive price.

Conclusion:

Kineret 100 mg Injection 0.67 ml is an important treatment for autoimmune and inflammatory diseases. By effectively targeting inflammation, it provides significant relief to patients struggling with chronic conditions. If you are looking to buy Kineret, connect with The Indian Pharma (TIP) for authentic supply. For more details about pricing and availability, consult us today.

What is Kineret 100 mg/0.67 ml Injection used for? Kineret 100 mg/0.67 ml Injection is an immunosuppressive medicine used to treat rheumatoid arthritis, deficiency of interleukin-1 receptor antagonist (DIRA), and neonatal-onset multisystem inflammatory disease (NOMID), and COVID-19.

How does Kineret 100 mg/0.67 ml Injection work? Kineret blocks the action of a protein called interleukin, which causes inflammation. By doing so, it protects the body from the harmful effects of inflammatory proteins called cytokines.

Does Kineret 100 mg/0.67 ml Injection cause neutropenia? Yes, Kineret may cause neutropenia, which is a low level of white blood cells. This condition can increase the risk of infections. It is important to monitor your white blood cell count before starting treatment, every three months during treatment, and every four months for up to a year after treatment. If you notice any signs of infection, consult your doctor immediately.

Can Kineret 100 mg/0.67 ml affect my ability to get pregnant? There isn’t enough information to confirm how Kineret affects fertility. However, it should be avoided during pregnancy unless absolutely necessary. Women who can become pregnant should use effective contraception while taking Kineret. Always consult your doctor if you have concerns.

Where can I find Kineret 100 mg/0.67 ml injections in India? If you are looking for reliable suppliers or need information about the Kineret 100 mg/0.67 ml price in India, consult a trusted provider like Indian Pharma Network (IPN) to ensure access to genuine medicine. Always prioritize legal and safe channels for purchasing medications.

Is it safe to take Kineret 100 mg/0.67 ml with etanercept? No, Kineret should not be taken with etanercept, a TNF inhibitor used for rheumatoid arthritis (RA). Combining these medicines can increase the risk of infections.

Can I take Kineret 100 mg/0.67 ml with warfarin or phenytoin? You should talk to your doctor before using Kineret with medicines like warfarin or phenytoin. Your doctor may need to adjust the dosage or monitor you closely.

Can I buy Kineret if it is not available or approved in my country? Yes, you can buy Kineret 100 mg/0.67 ml injection if it is not available in your country. Simply contact Indian Pharma Network (IPN) via Call/WhatsApp at +91 9310090915 or TOLL-FREE: 1800-889-1064 to facilitate access to Kineret 100 mg/0.67 ml injection through legal channels.

[quirksphere]

Understanding Inflammation Blood Markers: What They Are and Why They Matter

Inflammation is a natural response of the body to injury or infection. It’s your immune system’s way of saying, “Hey, something’s not right here!” While acute inflammation can be a helpful part of the healing process, chronic inflammation can lead to a host of health issues, from heart disease to autoimmune disorders. But how do we know if inflammation is lurking in our bodies? Enter inflammation blood markers—the unsung heroes of health diagnostics! In this article, we’ll explore what inflammation blood markers are, why they matter, and how they can provide insight into your overall health.

What Are Inflammation Blood Markers?

Inflammation blood markers are specific substances found in your blood that indicate the presence of inflammation in the body. These markers are often measured through routine blood tests and can help healthcare professionals assess your inflammatory status. Some common inflammation blood markers include:

C-Reactive Protein (CRP): This protein is produced by the liver in response to inflammation. Higher levels of CRP in the blood can indicate acute inflammation due to infection, injury, or chronic inflammatory conditions.

Erythrocyte Sedimentation Rate (ESR): This test measures how quickly red blood cells settle at the bottom of a test tube. A faster sedimentation rate can be a sign of inflammation in the body.

Fibrinogen: This is a protein involved in blood clotting, but it also acts as a marker for inflammation. Elevated fibrinogen levels can indicate an inflammatory response.

Interleukins: These are a group of cytokines (signaling molecules) that play a role in immune responses. Some interleukins, such as IL-6, can be measured to assess inflammation levels.

Tumor Necrosis Factor-alpha (TNF-alpha): This is another cytokine that is involved in systemic inflammation. Elevated levels can indicate chronic inflammatory conditions.

Why Do Inflammation Blood Markers Matter?

Monitoring inflammation blood markers can provide valuable insights into your health. Here are a few reasons why they matter:

Early Detection of Health Issues: Elevated inflammation markers can indicate underlying health problems, such as autoimmune diseases, infections, or chronic inflammatory conditions. Early detection can lead to timely intervention and better health outcomes.

Monitoring Chronic Conditions: For individuals with existing chronic conditions, such as rheumatoid arthritis or inflammatory bowel disease, tracking inflammation markers can help gauge disease activity and the effectiveness of treatment.

Assessing Risk Factors: Chronic inflammation is linked to various diseases, including heart disease, diabetes, and certain cancers. Monitoring inflammation markers can provide information about your risk factors and help guide lifestyle changes.

Personalized Treatment Plans: Understanding your inflammation levels can help healthcare providers create tailored treatment plans, including dietary changes, medications, or lifestyle modifications.

How to Keep Your Inflammation Markers in Check

If you’re concerned about inflammation or want to keep your inflammation markers in a healthy range, here are some tips to consider:

Adopt an Anti-Inflammatory Diet: Focus on whole, nutrient-dense foods such as fruits, vegetables, whole grains, lean proteins, and healthy fats. Foods rich in omega-3 fatty acids (like salmon and walnuts) and antioxidants (like berries and leafy greens) can help combat inflammation.

Stay Active: Regular physical activity can help reduce inflammation and improve overall health. Aim for at least 150 minutes of moderate exercise each week, including aerobic activities and strength training.

Manage Stress: Chronic stress can contribute to inflammation. Incorporate stress-reducing practices into your routine, such as mindfulness, yoga, meditation, or simply taking time to relax and unwind.

Get Enough Sleep: Quality sleep is crucial for maintaining a healthy immune system and reducing inflammation. Aim for 7-9 hours of restful sleep each night.

Stay Hydrated: Drinking plenty of water helps support overall health and can aid in reducing inflammation. Aim for at least eight 8-ounce glasses of water per day, or more if you’re active.

Limit Processed Foods: Highly processed foods, sugary snacks, and trans fats can contribute to inflammation. Try to minimize these foods in your diet and focus on whole, unprocessed options.

Consider Supplements: Some supplements, such as omega-3 fatty acids, curcumin (found in turmeric), and ginger, may help reduce inflammation. Consult with a healthcare professional before starting any new supplements.

Conclusion

Understanding inflammation blood markers can empower you to take charge of your health. By keeping an eye on these markers, you can gain valuable insights into your body’s inflammatory status and make informed decisions about your lifestyle and healthcare. Whether you’re looking to prevent chronic diseases or manage existing conditions, being proactive about inflammation can lead to a healthier, happier you. So, the next time you hear about inflammation markers, remember—they’re not just numbers; they’re a window into your overall health!

[videoddd]

DMARDs for Ankylosing Spondylitis: Key Insights

Two groups of biologics have been approved for the treatment of AS, and others are in development. TNF inhibitors One of the main inflammatory factors in AS is a protein called tumor necrosis factor-alpha or TNF-alpha. TNF-alpha is a type of cytokine, a small protein that plays a large role in mediating acute and chronic inflammation by signaling the immune system to get to work. [5] TNF-alpha…

[many-to-mention10001]

What are inflammatory biomarkers?

What are inflammatory biomarkers? Inflammatory biomarkers are molecules found in blood or other body fluids that indicate the presence and intensity of inflammation in the body.

What are the common inflammatory biomarkers? Common biomarkers include C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukins (e.g., IL-6), tumor necrosis factor-alpha (TNF-α), and procalcitonin.

What conditions can inflammatory biomarkers detect? They can indicate infections, autoimmune diseases (e.g., rheumatoid arthritis), cardiovascular diseases, and some cancers.

What does a high CRP level indicate? High CRP levels suggest acute or chronic inflammation, often due to infection, autoimmune diseases, or tissue injury.

What is ESR, and what does it measure? ESR measures the rate at which red blood cells settle in a test tube, with faster rates indicating inflammation.

[blueoaknx]

The Connection Between Damaged Mitochondria and Arthritis

Mitochondria are integral organelles responsible for various critical cellular functions, primarily energy production through oxidative phosphorylation. They are involved in maintaining cellular homeostasis, regulating metabolism, modulating calcium levels, and controlling apoptosis. Emerging evidence has highlighted mitochondrial dysfunction as a key contributor to a variety of diseases, including arthritis. This formal overview aims to explore the complex relationship between damaged mitochondria and arthritis, focusing on the molecular mechanisms that link mitochondrial dysfunction to the pathogenesis of inflammatory joint diseases, particularly rheumatoid arthritis (RA) and osteoarthritis (OA).

Mitochondrial Structure and Function

Mitochondria are double-membraned organelles found in eukaryotic cells, and they are crucial for cellular energy metabolism. Their primary role is the production of adenosine triphosphate (ATP) via oxidative phosphorylation, a process that takes place in the inner mitochondrial membrane. During this process, the electron transport chain (ETC) generates a proton gradient across the inner membrane, which drives ATP synthesis through ATP synthase. However, this process also generates reactive oxygen species (ROS) as byproducts, primarily from complexes I and III of the ETC. Under normal physiological conditions, ROS are neutralized by antioxidants, including superoxide dismutase (SOD), catalase, and glutathione. However, under pathological conditions, excessive ROS production can lead to oxidative stress, contributing to cellular damage and dysfunction.

In addition to ATP production, mitochondria have essential roles in calcium buffering, apoptosis regulation, and the maintenance of cellular integrity. Damage to these organelles disrupts these functions, contributing to various diseases, including arthritis.

Mitochondrial Dysfunction in Arthritis

Arthritis is a group of diseases characterized by inflammation and degeneration of the joints. It includes conditions like rheumatoid arthritis (RA), an autoimmune disease, and osteoarthritis (OA), a degenerative disease. In both types of arthritis, mitochondrial dysfunction has been identified as a critical factor that exacerbates disease progression through several mechanisms, including increased oxidative stress, immune activation, and tissue damage.

1. Oxidative Stress and Mitochondrial Damage

Oxidative stress is a hallmark of both RA and OA, and mitochondria are central to its production. In these conditions, mitochondrial dysfunction results in an increase in ROS production, overwhelming the cell’s antioxidant defenses. This oxidative stress leads to the modification of cellular structures, including proteins, lipids, and DNA, causing further mitochondrial damage. In RA, pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6) stimulate immune cells like macrophages and neutrophils to release large amounts of ROS. These ROS contribute to the local inflammatory environment and accelerate joint destruction by damaging mitochondria and amplifying oxidative stress.

Mitochondrial damage results in a feedback loop where impaired mitochondrial function generates more ROS, further promoting inflammation. For instance, in RA, markers of oxidative damage such as 8-hydroxy-2'-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) have been found to correlate with disease activity, suggesting a direct relationship between mitochondrial dysfunction and disease severity.

2. Mitochondrial DNA Damage and Inflammatory Signaling

Mitochondrial DNA (mtDNA) is particularly vulnerable to oxidative damage due to its proximity to the ETC, where ROS are produced during ATP synthesis. Unlike nuclear DNA, mtDNA is not protected by histones and has limited repair mechanisms, making it prone to mutations. Damage to mtDNA impairs mitochondrial function and can lead to the release of mtDNA fragments into the cytoplasm or extracellular space.

In the context of arthritis, mtDNA damage has been implicated in immune activation. When damaged mtDNA is released into the cytoplasm, it is recognized by pattern recognition receptors (PRRs), such as toll-like receptors (TLRs), on immune cells. TLRs, particularly TLR9, activate downstream inflammatory signaling pathways that lead to the production of pro-inflammatory cytokines such as TNF-α and IL-6. This further exacerbates the inflammatory response in joints and contributes to the progression of arthritis. Studies have shown that the presence of mtDNA fragments in the serum of RA patients correlates with disease activity, indicating the role of mtDNA in driving inflammation.

3. Mitochondrial Dynamics and Arthritis Pathogenesis

Mitochondrial dynamics refer to the continuous processes of mitochondrial fission (division) and fusion (joining), which maintain mitochondrial function and integrity. Fission allows for the removal of damaged mitochondria, while fusion helps to integrate mitochondrial contents and maintain a healthy mitochondrial pool. Imbalance between fission and fusion is associated with several diseases, including arthritis.

In the case of RA, excessive mitochondrial fission and reduced fusion have been observed. This imbalance results in mitochondrial fragmentation, which impairs mitochondrial function, increases ROS production, and contributes to cellular stress. Fission is regulated by proteins such as dynamin-related protein 1 (Drp1) and fission 1 protein (Fis1), while fusion is controlled by mitofusins (Mfn1 and Mfn2) and optic atrophy 1 (OPA1). Dysregulation of these proteins in RA leads to a fragmented mitochondrial network, which exacerbates oxidative stress and inflammation in synovial tissues.

4. Mitochondrial-Dependent Cell Death

Mitochondria are also central regulators of programmed cell death, particularly apoptosis. In the pathogenesis of arthritis, excessive or dysregulated apoptosis contributes to joint destruction. Mitochondrial dysfunction plays a critical role in the intrinsic apoptotic pathway by releasing pro-apoptotic factors such as cytochrome c and apoptosis-inducing factor (AIF). These factors activate caspase-dependent and caspase-independent pathways, leading to the death of synovial cells and cartilage cells, which contributes to the progressive tissue damage observed in both RA and OA.

Furthermore, mitochondrial permeability transition pore (mPTP) opening, which is induced by oxidative stress, can lead to necrosis, a form of uncontrolled cell death. Necrotic cell death in the joints increases inflammation and tissue degradation, particularly in OA, where cartilage breakdown is a hallmark feature.

Therapeutic Approaches Targeting Mitochondrial Dysfunction in Arthritis

Given the significant role of mitochondrial dysfunction in the pathogenesis of arthritis, various therapeutic strategies aimed at improving mitochondrial function are under investigation.

1. Mitochondrial Antioxidants

Mitochondrial-targeted antioxidants, such as MitoQ and MitoTEMPO, have been developed to selectively accumulate in mitochondria, where they can neutralize ROS and reduce oxidative stress. These compounds have shown promise in preclinical models of arthritis, where they help to reduce inflammation, protect mitochondrial function, and limit joint damage. The use of mitochondrial antioxidants could be an effective strategy to mitigate oxidative stress in arthritic conditions.

2. Mitochondrial Biogenesis Enhancement

Another potential therapeutic approach is the activation of mitochondrial biogenesis, the process by which new mitochondria are formed to compensate for damaged mitochondria. Agents that activate peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a key regulator of mitochondrial biogenesis, could help restore mitochondrial function in arthritic tissues. Compounds such as resveratrol and NAD+ precursors are under investigation for their ability to promote mitochondrial biogenesis and improve cellular metabolism in arthritis.

3. Mitochondrial Dynamics Modulation

Restoring the balance between mitochondrial fission and fusion is another therapeutic strategy. Inhibiting excessive mitochondrial fission or promoting mitochondrial fusion may help maintain mitochondrial integrity and reduce inflammation in arthritis. Drugs targeting Drp1 or enhancing Mfn1/Mfn2 activity are potential candidates for modulating mitochondrial dynamics in arthritic diseases.

4. Mitophagy Enhancement

Mitophagy, the selective autophagic degradation of damaged mitochondria, is essential for maintaining mitochondrial quality. Enhancing mitophagy through the use of compounds like spermidine or activators of the PINK1/PARK2 pathway could help eliminate dysfunctional mitochondria and reduce inflammation, making it a promising therapeutic approach in arthritis.

Conclusion

Mitochondrial dysfunction plays a critical role in the pathogenesis of arthritis, contributing to oxidative stress, inflammation, and joint damage. The intricate relationship between damaged mitochondria and immune activation highlights the importance of targeting mitochondrial health in the treatment of arthritis. Emerging therapeutic strategies aimed at restoring mitochondrial function, reducing oxidative stress, and modulating mitochondrial dynamics hold promise for improving the management of arthritis and preventing joint destruction. Further research into mitochondrial biology and its role in arthritis is essential for the development of more effective, targeted therapies for these debilitating conditions.

[delifoodsmanufacturer]

The Impact of Iranian Propolis on Diabetes: A Randomized Double-Blind Clinical Trial

A groundbreaking study conducted by scholars at Ahvaz Jundishapur University of Medical Sciences in Iran has shed light on the potential benefits of Iranian propolis in managing type 2 diabetes. This randomized double-blind clinical trial evaluated the effects of propolis on glucose metabolism, lipid distribution, insulin resistance, kidney and liver function, and inflammatory biomarkers in patients with type 2 diabetes . Study Details The study, which took place from September 2017 to March 2018, involved 100 participants diagnosed with type 2 diabetes, aged between 35 and 85 years. Participants were not on insulin treatment, had no severe liver or kidney dysfunction, and had a diabetes history of no more than 10 years. They were randomly divided into two groups: one receiving propolis and the other a placebo . Propolis Intervention The propolis group consumed Iranian propolis capsules (500 mg twice daily), while the placebo group received capsules identical in appearance. The intervention lasted for 90 days, with no changes to the participants' diet or exercise routines. Measurements were taken at the start and after 90 days . Significant Findings - Improvement in Glucose Metabolism and Insulin Resistance: Compared to the placebo group, the propolis group experienced an average decrease of 8% in glycated hemoglobin, 28.6% in 2-hour postprandial blood glucose, and 50.8% in insulin levels. However, there was no significant difference in fasting blood glucose between the two groups. The propolis group's glycated hemoglobin decreased by an average of 0.98% over 90 days, with insulin levels dropping by as much as 45% . - Improvement in Lipid Metabolism: The propolis group showed a significant increase of 10.6% in high-density lipoprotein (HDL) compared to the placebo group. However, there were no significant differences in total cholesterol, low-density lipoprotein (LDL), triglycerides, and very-low-density lipoprotein (VLDL) between the two groups. The propolis group's HDL increased by 9.5% over 90 days . - Improvement in Kidney and Liver Function: The propolis group had significantly lower concentrations of liver transaminases (ALT and AST) and blood urea nitrogen (BUN) . - Anti-inflammatory Effects: The propolis group experienced a significant decrease of 60.43% in C-reactive protein and 49.6% in tumor necrosis factor-alpha (TNF-α) compared to the placebo group . Conclusion In conclusion, Iranian propolis has shown beneficial effects in reducing postprandial blood glucose, insulin, insulin resistance, and inflammatory cytokines, particularly in glucose metabolism and insulin resistance. These findings suggest that propolis could be a valuable addition to the management of type 2 diabetes . Final Thoughts The integration of natural remedies like Iranian propolis into diabetes treatment protocols may offer a complementary approach for patients seeking to improve their glycemic control and overall health. It is essential to consult with healthcare professionals before incorporating propolis or any supplement into a diabetes management plan. Read the full article

[mitalipingale]

The Tumor Necrosis Factor (TNF) Alpha Inhibitors Market in 2023 is US$ 41.88 billion, and is expected to reach US$ 44.35 billion by 2031 at a CAGR of 0.7%.

[moleculardepot]

Recombinant Canine TNF-alpha

Recombinant Canine TNF-alpha Catalog number: B2017868 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 μg Molecular Weight or Concentration: ~17.3 kDa Supplied as: Powder Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: TNFA, cTNF, cachectin, tumor necrosis factor ligand superfamily member 2 Grade: Biotechnology grade. All products…

[medicapharmabv]

The Role of Imiquimod in Dermatological Therapy: Benefits and Risks

Imiquimod is a versatile medication widely used in dermatology. This blog explores its benefits, potential risks, and why MedicaPharma is the preferred source for purchasing imiquimod.

Mechanism of Action

How Imiquimod Works:

Immune System Stimulation: Imiquimod activates toll-like receptors (TLRs) on immune cells. This activation triggers a cascade of immune responses, including the production of cytokines.

Cytokine Production: Key cytokines such as interferon-alpha, tumor necrosis factor-alpha (TNF-alpha), and interleukins are produced. These cytokines enhance the body’s ability to target and eliminate abnormal skin cells.

Targeting Abnormal Cells: The immune activation helps in clearing various skin conditions by promoting the destruction of infected or precancerous cells.

Benefits and Advantages

Key Benefits of Imiquimod:

Non-Invasive Treatment: Imiquimod is applied topically, offering a non-invasive alternative to surgical or other more invasive dermatological treatments.

Versatility: It is effective for a range of dermatological conditions, including viral infections like genital warts, precancerous lesions such as actinic keratosis, and certain skin cancers.

Convenient Application: The topical application of imiquimod is user-friendly and well-tolerated, making it a convenient option for patients.

Side Effects and Risks

Managing Side Effects:

Local Reactions: Common side effects include skin irritation, redness, and itching at the site of application. These are generally mild and manageable.

Systemic Symptoms: Although less common, systemic effects such as flu-like symptoms (fever, fatigue) can occur. Monitoring and consultation with a healthcare provider can help manage these risks.

Regular Monitoring: It is important to monitor for any adverse effects to ensure the treatment remains effective and comfortable for the patient.

Why Buy Imiquimod from MedicaPharma

The MedicaPharma Advantage:

Quality Assurance: MedicaPharma’s imiquimod is produced according to stringent GMP standards, ensuring high quality and efficacy.

Reliable Distribution: MedicaPharma offers consistent and reliable distribution, making it a trusted source for purchasing imiquimod.

Trusted Supplier: MedicaPharma’s commitment to quality and customer service positions them as a preferred choice for healthcare providers and patients.

Conclusion

Imiquimod is a valuable tool in dermatological therapy, offering a non-invasive and effective treatment for various skin conditions. For high-quality imiquimod, MedicaPharma is a dependable supplier that ensures optimal therapeutic outcomes.

[suhaana240]

How to Activate Your Brain in the Morning for Maximum Productivity

Mornings can be a struggle, but learning how to activate your brain in the morning can set the tone for a productive day. Many people wonder if their brain works better in the morning, and the answer is often yes - with the right strategies. Just as athletes warm up before a game, individuals can benefit from morning brain exercises to fully wake up and kickstart their cognitive functions.

Jim Kwik, a renowned brain coach, emphasizes the importance of a morning routine to optimize brain performance. His approach combines physical activity, sensory stimulation, and nourishment to help people shake off grogginess and boost mental clarity. By incorporating these techniques, anyone can learn how to warm up their brain in the morning, leading to improved focus, creativity, and overall productivity throughout the day.

Establish a Consistent Morning Routine

Establishing a consistent morning routine is crucial for activating the brain and setting the tone for a productive day. Waking up at the same time every day, including weekends, helps improve sleep quality and reinforces the body's circadian rhythm 1. This consistency acts as a cue to the body about when to be awake and when to sleep 1.

To break the habit of hitting the snooze button, which can negatively affect physical health and increase stress 2, try these strategies:

Use a traditional alarm clock placed away from the bed 2

Count down 3-2-1 and sit up immediately 2

Expose yourself to natural light upon waking 2

Consistency in wake-up times can help stabilize learning, memory, and concentration capabilities 3. Ideally, aim to wake up by 7:00 AM and be ready for sleep by 10:00 PM 3. This routine allows the brain to transition through theta and alpha waves, priming it for peak performance 4.

Engage in Physical Activity

Physical activity in the morning has a significant impact on brain activation and overall productivity. Regular morning walks can boost immune function, improve circulation, and support joint health 5. Studies have shown that individuals who walk at least 20 minutes a day, five days a week, experience 43% fewer sick days 5. Moreover, walking two miles daily can reduce the risk of stroke 5.

High-intensity interval training (HIIT) has been linked to better memory and brain volume in older adults. A study found that HIIT workouts improved memory and preserved brain volume, with benefits lasting up to five years 6. HIIT sessions typically involve four-minute bouts of hard exercise at 80-95% of maximum heart rate, interspersed with three-minute recovery periods 6.

HIIT workouts can also reduce levels of tumor necrosis factor alpha (TNF-α), a protein associated with chronic inflammation, and increase levels of brain-derived neurotrophic factor (BDNF), which stimulates neuron growth and repair 6.

Stimulate Your Senses

Activating the senses in the morning can jumpstart the brain for maximum productivity. Light exposure plays a crucial role in regulating the body's circadian rhythm. Bright, blue-rich light in the morning promotes wakefulness and improves cognitive performance 7. To harness these benefits, individuals can spend time outdoors, sit near windows, or use light boxes 7.

Auditory stimulation through binaural beats can enhance focus and creativity. Listening to specific frequencies has been linked to reduced anxiety and improved concentration 8. For instance, binaural beats in the lower beta range (14 to 30 Hz) have been associated with increased alertness and problem-solving abilities 

Aromatherapy can also boost productivity. Scents like lemon, peppermint, and eucalyptus have been found to promote concentration and mental clarity 9. In fact, a study showed that lemon fragrance in workspaces led to a 54% decrease in typing errors 10.

Nourish Your Body and Mind

Proper nutrition plays a crucial role in activating the brain for maximum productivity. A brain-boosting smoothie can provide essential nutrients to support cognitive function and mental clarity. This delicious concoction includes ingredients known to enhance focus, memory, and overall brain health 11.

Key components of a brain-boosting smoothie include:

Berries: Rich in antioxidants, particularly anthocyanins, which may improve cognitive function 11.

Banana: Provides natural sugars for quick energy and essential vitamins for brain health 11.

Avocado: Contains healthy fats that support blood flow and cognitive function 11.

Leafy greens: Packed with neuroprotective vitamins and minerals 11.

Turmeric: Contains curcumin, which has anti-inflammatory and antioxidant benefits 11.

These ingredients work together to provide a nutrient-dense start to the day, supporting brain health and overall well-being.

Conclusion

Activating your brain in the morning has a significant impact on your productivity throughout the day. By establishing a consistent routine, engaging in physical activity, stimulating your senses, and nourishing your body and mind, you can set yourself up for success. These strategies work together to shake off grogginess, boost mental clarity, and enhance focus.

Implementing these techniques is not just about improving your workday; it's about enhancing your overall well-being. The benefits extend beyond increased productivity to include better physical health, improved cognitive function, and reduced stress levels. By making these practices a part of your daily routine, you're investing in your long-term health and success, setting the stage to tackle challenges with a clear and energized mind.

Become “one” with the Universe in 7 mins

[quirksphere]

Understanding Inflammatory Biomarkers: What They Are and Why They Matter

Inflammation is a natural process by which the body responds to injury, infection, or harmful stimuli. While it plays a crucial role in healing and defense, chronic or excessive inflammation can contribute to various diseases, such as cardiovascular disorders, diabetes, autoimmune conditions, and even cancer. To better understand and manage inflammation-related health conditions, researchers and healthcare providers rely on inflammatory biomarkers.

What Are Inflammatory Biomarkers?

Inflammatory biomarkers are measurable molecules in the blood, tissues, or other bodily fluids that indicate the presence or extent of inflammation in the body. These biomarkers are typically proteins, enzymes, or metabolites produced by the immune system or damaged tissues during an inflammatory response. By measuring their levels, healthcare providers can gain insights into a patient’s health status, track disease progression, or assess the effectiveness of treatments.

Types of Inflammatory Biomarkers

Inflammatory biomarkers can be broadly classified based on their origin or function. Some of the most commonly studied biomarkers include:

C-Reactive Protein (CRP): CRP is produced by the liver in response to inflammation. Elevated CRP levels are often associated with acute inflammation, infections, or chronic conditions like rheumatoid arthritis and cardiovascular disease.

Erythrocyte Sedimentation Rate (ESR): ESR measures how quickly red blood cells settle at the bottom of a test tube. A higher sedimentation rate can indicate inflammation or infection.

Cytokines: Cytokines are signaling proteins that regulate immune and inflammatory responses. Common pro-inflammatory cytokines include interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α).

Fibrinogen: A protein involved in blood clotting, fibrinogen levels often rise during systemic inflammation and are linked to cardiovascular risk.

Serum Amyloid A (SAA): This acute-phase protein is produced in response to inflammatory signals and can serve as an indicator of infection or chronic inflammation.

Prostaglandins and Leukotrienes: These lipid molecules mediate inflammatory processes and are often studied in relation to asthma, arthritis, and other inflammatory conditions.

How Are Inflammatory Biomarkers Measured?

Inflammatory biomarkers are typically measured using blood tests, though some can be detected in saliva, urine, or tissue samples. Advanced laboratory techniques such as enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and multiplex immunoassays are used to quantify these molecules with precision.

Clinical Applications of Inflammatory Biomarkers

Inflammatory biomarkers have a wide range of applications in medicine and research:

Disease Diagnosis and Monitoring: Elevated levels of certain biomarkers can help identify inflammatory or autoimmune conditions, such as lupus, rheumatoid arthritis, or inflammatory bowel disease. They are also used to monitor disease progression.

Cardiovascular Risk Assessment: High levels of CRP and fibrinogen are associated with an increased risk of heart attacks and strokes, making them valuable in assessing cardiovascular health.

Therapeutic Guidance: Biomarkers can help evaluate the effectiveness of anti-inflammatory medications, allowing for personalized treatment strategies.

Predicting Outcomes: In conditions like sepsis or COVID-19, elevated biomarkers such as IL-6 and CRP can predict disease severity and guide critical care interventions.

The Future of Inflammatory Biomarkers

Advances in genomics, proteomics, and bioinformatics are driving the discovery of novel inflammatory biomarkers. Researchers are exploring multi-biomarker panels that provide a more comprehensive picture of inflammation. Additionally, wearable technologies capable of monitoring biomarkers in real-time are on the horizon, promising to revolutionize how inflammation is tracked and managed.

Conclusion

Inflammatory biomarkers are powerful tools for understanding the body’s response to injury and disease. They offer invaluable insights into diagnosing, monitoring, and treating a wide range of conditions. As research progresses, these biomarkers will likely play an even greater role in precision medicine, helping to improve outcomes for patients worldwide. By staying informed about these advancements, both healthcare providers and patients can better navigate the complexities of inflammation-related health issues.